迪哲医药(688192.SH)发预亏，预计2025年度归母净亏损7.7亿元左右

Core Viewpoint - Dige Pharmaceutical (688192.SH) expects a net loss of approximately 770 million yuan for the fiscal year 2025, which represents a reduction in losses of about 75.96 million yuan compared to the previous year, indicating a year-on-year decrease in losses of approximately 8.98% [1] Financial Summary - The projected net loss for 2025 is around 770 million yuan [1] - The expected reduction in losses compared to the previous year is approximately 75.96 million yuan [1] - The year-on-year percentage decrease in losses is about 8.98% [1]